NF-κB Inhibitors Market to Witness Accelerated Expansion Across the 7MM through 2034 | DelveInsight

The NF-κB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory diseases where NF-κB plays a central role. Additionally, the expected launch of emerging NF-κB inhibitors such as BioVie' bezisterim (NE3107), Entero Therapeutics'...